MedPath

Temotero 20

Brand Name: Temotero 20

Generic Name: TEMOZOLOMIDE

Active
Registration Number

DRP-6720

Dosage Form

Capsule

Issuance Date

May 1, 2023

Expiry Date

June 20, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength20 mg
PackagingType I Amber Glass Bottle x 5's

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

TEMOZOLOMIDEActive
Monograph: Temozolomide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform